Aurobindo Pharma has reported results for first quarter ended June 30, 2012.
On standalone basis, the company has reported a net loss of Rs 49.84 crore for the quarter ended June 30, 2012 against net loss of Rs 101.58 crore for the corresponding period last fiscal. However, total income increased by 9.07% at Rs 1130.61 crore during the quarter under review from Rs 1036.60 crore in the year-ago period.
On consolidated basis, the company has reported a net loss of Rs 128.91 crore for the quarter ended June 30, 2012 against net loss of Rs 122.80 crore for the corresponding period last fiscal. However, total income increased by 12.22% at Rs 1216.63 crore during the quarter under review from Rs 1084.16 crore in the year-ago period.
